SEC Form 4: Rivard Paul bought $28,080 worth of shares (25,000 units at $1.12), increasing direct ownership by 11% to 250,000 units
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
MYMD
MyMD Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Listed since
- 2014
Get push alerts for MYMD
Full MYMD profile on Quantisnow Follow MYMD and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time